Aviragen Therapeutics Stock Price (NASDAQ:AVIR)

Add to My Stocks
$0.63 $0.02 (3.08%) AVIR stock closing price Feb 24, 2017 (Closing)
Prev Close* : $0.65
Market Cap:
Day Low: $0.6
52 Week Low: $0.60
Open: $0.63
Volume: 39909
Day High: $0.63
52 Week High: $2.00

Latest Stock Market News

Latest Articles

Aviragen Therapeutics News - From Partners

AVIR Stockcharts

View AVIR PE ratio, PS ratio stocks charts and compare with peers.
AVIR Chart
Note: Compare Aviragen Therapeutics stock price history with the index and industry peers.

Aviragen Therapeutics Valuation

PS ratio (
price to sales ratio
PB ratio (
price to book ratio

Aviragen Therapeutics Financial Ratios

Asset Turnover
Receivables Turnover
Debt to Equity

AVIR Industry Peers

Company Price Change (%)
Sierra Oncology (SRRA)1.460.04 (2.82%)
Champions Oncology (CSBR)3.280.06 (1.86%)
Glaxosmithkline (GSK)41.560.07 (0.17%)
Gilead Sciences (GILD)69.940.57 (0.82%)
Novavax (NVAX)1.380 (0%)
Sarepta Therapeutics (SRPT)32.021.87 (6.2%)
Biocryst Pharma (BCRX)5.490.11 (1.96%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Cempra (CEMP)4.050.9 (28.57%)
La Jolla Pharma (LJPC)19.871.65 (9.06%)
Portola Pharma (PTLA)33.51.34 (4.17%)
ImmunoGen (IMGN)2.710.1 (3.83%)
Egalet (EGLT)4.930.14 (2.92%)
Tetraphase Pharmaceuticals (TTPH)5.330.13 (2.5%)
Achaogen (AKAO)23.650.54 (2.34%)
Top gainers from Medical-Drugs industry
* As of Feb 25, 2017
CompanyPriceChange (%)
AVADEL PHARMA (AVDL)10.270.49 (4.55%)
Ignyta (RXDX)8.70.4 (4.4%)
AcelRx Pharma (ACRX)30.1 (3.23%)
Depomed (DEPO)16.320.51 (3.03%)
Lannett Co (LCI)22.90.65 (2.76%)
MediWound (MDWD)5.850.15 (2.5%)
Valeant (VRX)16.180.4 (2.41%)
Top losers from Medical-Drugs industry
* As of Feb 25, 2017

Aviragen Therapeutics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues9.3M24.6M68.7M33.6M0.63M
Net Income-25.4M-19.1M-11M-8.7M-2.73M
Total Operating Expense34.5M40.49M29.1M35.3M3.5M
view Aviragen Therapeutics Inc income statement
balance sheet20162015201420132012
Total Assets72.7M79.4M114M84.3M92.95M
Total Liabilities26.5M9.9M27.1M16.1M35.61M
Shareholders Equity46.2M69.5M86.9M68.2M57.33M
view Aviragen Therapeutics Inc balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities9.1M-11.5M3.6M-4.5M-0.57M
Net Cash From (Used By) Operating Activities-14.1M-9.6M-3.3M-13.9M-3.74M
Increase (Decrease) In Prop Plant And Equipment-0.2M0.3M-0.1M-1M-
view Aviragen Therapeutics Inc cashflow statement

Aviragen Therapeutics Inc Stock News - Partner Headlines

Aviragen Therapeutics Stock Message Board

As of last trading day, Aviragen Therapeutics stock price was 0.63. Stock price or share price can be used to find the total market value of a company. Aviragen Therapeutics market cap stands at 24.95M as of 24 Feb, 2017. Investors can use valuation multiples like the P/E ratio, price to sales ratio etc. for performing Aviragen Therapeutics stock analysis.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Aviragen Therapeutics is worth a lot, it will most likely be reflected in an inflated Aviragen Therapeutics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 39909 AVIR shares were traded yesterday, and Aviragen Therapeutics stock chart shows that the AVIR stock quote hit a day high of 0.63 and day low of 0.6. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Aviragen Therapeutics stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.